Literature DB >> 3825607

Phenytoin plasma levels after intraoperative administration, for the prevention of post-craniotomy seizures.

M Tsolaki, M Yannacou-Peftoulidou, P Grammaticos, E Sofianos, G Foroglou.   

Abstract

Since in a previous study (preliminary report) (18) the iv. administration of 15 mg X kg-1 of phenytoin (PNT) over 30 min in men produced toxic levels (25 micrograms/ml), a smaller iv. dose of 7 mg X kg-1 was given during anaesthesia to 80 patients under going craniotomy, for the prevention of post-operative seizures. Plasma PNT concentrations were studied in 22 patients before its iv. infusion 20 min, 40 min, and 1, 2, 3, 5, 8 and 12 hours later. Mean serum phenytoin levels were 9.3, 31.9, 27.8, 25.5, 19.4, 17.2, 15.4 and 19.2 micrograms/ml respectively. In this study it appeared that although the initial dose was 50% smaller than before, toxic levels were still encountered one hour after PNT administration (therapeutic range 10-25 micrograms/ml). Bearing in mind that in both our studies PNT appeared to have approximately the same efficacy in seizure prevention (from 95-97%), we suggest, that 7-10 mg X kg-1 would be adequate if administered as an intraoperative iv. infusion over an hour and that whenever possible serial serum levels should be monitored.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3825607     DOI: 10.1007/bf01456348

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  18 in total

1.  Relation of prophylactic medication to the occurrence of early seizures following craniocerebral trauma.

Authors:  B L Rish; W F Caveness
Journal:  J Neurosurg       Date:  1973-02       Impact factor: 5.115

2.  Clinicopathological Conference. Diagnostic difficulties in a case of polypharmacy. Demonstrated at the Royal College of Physicians of London.

Authors: 
Journal:  Br Med J       Date:  1977-01-22

3.  Phenytoin prophylaxis for posttraumatic seizures.

Authors:  A L Johnson; P Harris; J K McQueen; D H Blackwood; R M Kalbag
Journal:  J Neurosurg       Date:  1983-10       Impact factor: 5.115

4.  Cellular bases of barbiturate and phenytoin anticonvulsant drug action.

Authors:  R L Macdonald; M J McLean
Journal:  Epilepsia       Date:  1982       Impact factor: 5.864

5.  Effect of phenytoin on bone and vitamin D metabolism.

Authors:  R D Bell; C Y Pak; J Zerwekh; D E Barilla; M Vasko
Journal:  Ann Neurol       Date:  1979-04       Impact factor: 10.422

6.  Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon?

Authors:  L Durelli; R Mutani; G P Sechi; F Monaco; N Glorioso; G Gusmaroli
Journal:  Arch Neurol       Date:  1985-11

7.  Cerebellar degeneration due to chronic phenytoin therapy.

Authors:  L W McLain; J T Martin; J H Allen
Journal:  Ann Neurol       Date:  1980-01       Impact factor: 10.422

8.  Toxic effect of phenytoin on developing cortical neurons in culture.

Authors:  K F Swaiman; E A Neale; B K Schrier; P G Nelson
Journal:  Ann Neurol       Date:  1983-01       Impact factor: 10.422

9.  Phenytoin: pharmacokinetics and clinical therapeutics.

Authors:  C W Olanow; A L Finn
Journal:  Neurosurgery       Date:  1981-01       Impact factor: 4.654

10.  Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy.

Authors:  J B North; R K Penhall; A Hanieh; C S Hann; R G Challen; D B Frewin
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

View more
  4 in total

1.  Antiepileptic drugs as prophylaxis for postcraniotomy seizures.

Authors:  Janette Greenhalgh; Jennifer Weston; Yenal Dundar; Sarah J Nevitt; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

2.  Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels.

Authors:  A Levati; G Savoia; F Zoppi; L Boselli; C Tommasino
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects.

Authors:  L F Beenen; J Lindeboom; D G Kasteleijn-Nolst Trenité; J J Heimans; F J Snoek; D J Touw; H J Adèr; H A van Alphen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

Review 4.  Antiepileptic drugs as prophylaxis for postcraniotomy seizures.

Authors:  Janette Greenhalgh; Jennifer Weston; Yenal Dundar; Sarah J Nevitt; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2018-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.